Two Years versus One Year of Tianjiu Therapy in Sanfu Days for Chronic Asthma: A Clinical Efficacy Observation Trial

Abstract EN

Background.

Tianjiu therapy has established efficacy against chronic asthma with related symptoms or the medication need during asthma attack.

This study aimed to explore the optimal duration of Tianjiu therapy for asthma.

Methods.

This study was a self-comparison-to-the-baseline study, which comparing treatment with Tianjiu therapy for 1 year and 2 years in the same 102 chronic asthma patients.

Totally 6 sessions of Tianjiu treatment were provided, 3 sessions in a year as a course of treatment and totally two years treatment.

The primary endpoint was the number of asthma related symptoms which frequently appeared in asthma patients and the frequency of bronchodilator used during asthma attack.

Results.

The frequency of bronchodilator used during asthma attack significantly improved (χ2=46.276, P=0.000).

But the number of asthma related symptoms which frequently appeared in asthma patients added by 1.38 points (95% CI, 0.25 to 2.51), 2.93±0.41 in 1-year group and 4.31±0.41 in the 2-years group (P<0.05).

Conclusions.

The effect of 2 years Tianjiu therapy was not as effective as 1 year such treatment for asthma, but the second year Tianjiu therapy was still needed because it has a role to consolidate the curative effect of Tianjiu therapy for asthma.